← Retour au Screener

Sector: Santé
Open in Terminal → AVTRLive chart · Key metrics · News · Smart money

Avantor, Inc.

AVTR Mid Cap

Healthcare · Medical Instruments & Supplies

Mis à jour: Jun 18, 2026, 22:21 UTC

8,35 €
+1.16% aujourd'hui
52W: 6,34 € – 13,90 €
52W Low: 6,34 € Position: 26.6% 52W High: 13,90 €

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
11.25x
P/E prévisionnel
P/S Ratio
1x
Cours/Ventes
EV/EBITDA
10.62x
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
5,7 Md €
Capitalisation boursière
Croissance du CA
Croissance du CA sur un an
Marge bénéficiaire
-8.42%
Marge nette
ROE
-9.44%
Rentabilité des capitaux propres
Beta
0.96
Sensibilité au marché
Positions vendeuses
7.21%
% du flottant vendu à découvert
Volume moyen
9,451,714
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
15 analysts
Avg. Price Target
8,44 €
+1.01% upside
Target Range
6,11 € – 16,58 €

About the Company

Sector: Healthcare Industry: Medical Instruments & Supplies Country: United States Employees: 13,500 Exchange: NYQ

Avantor, Inc. en bref

Avantor, Inc. (AVTR) is currently trading at 8,35 € with a market capitalization of 5,7 Md €. The 52-week range spans from 6,34 € to 13,90 €; the current price is 39.9% below the yearly high.

💰 Dividende

Avantor, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

15 analystes évaluent Avantor, Inc. (AVTR) au consensus : None. L'objectif de cours moyen est de 8,44 €, soit un potentiel de +1.01% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 6,11 € à 16,58 €.

Avantor, Inc. : la thèse d'investissement en détail

Avantor, Inc. (AVTR) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

Thèse d'investissement : forces et faiblesses

Points forts
  • Free cash flow positif
Points faibles
  • Actuellement non rentable

Aperçu technique

MM 50 jours
7,39 €
+12.99% vs. cours
MM 200 jours
9,20 €
-9.2% vs. cours
Sous le plus haut 52s
−39.9%
13,90 €
Au-dessus du plus bas 52s
+31.8%
6,34 €

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

Risque de marché (Bêta)
0.96 · Proche du marché
Évolue moins que le marché global
Positions vendeuses
7.21% · Élevé
% du flottant vendu à découvert
Dette/Capitaux propres
68.29 · Modéré
Dette totale / capitaux propres

The data points to relatively defensive market behavior, elevated short interest (7.21%).

Trading Data

50-Day MA: 7,39 €
200-Day MA: 9,20 €
Volume: 4,828,956
Avg. Volume: 9,451,714
Short Ratio: 3.86
P/B Ratio: 1.16x
Debt/Equity: 68.29x
Free Cash Flow: 427 M €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Avantor, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut